Logo image of EMO

CLEARBRIDGE ENERGY MIDSTREAM (EMO) Stock Price, Quote, News and Overview

NYSE:EMO - New York Stock Exchange, Inc. - US18469P2092 - Currency: USD

48.96  -1.52 (-3.01%)

Fundamental Rating

3

Taking everything into account, EMO scores 3 out of 10 in our fundamental rating. EMO was compared to 0 industry peers in the Unkown industry. The financial health of EMO is average, but there are quite some concerns on its profitability. EMO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year EMO was profitable.
EMO had a positive operating cash flow in the past year.
In multiple years EMO reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: EMO reported negative operating cash flow in multiple years.
EMO Yearly Net Income VS EBIT VS OCF VS FCFEMO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M

1.2 Ratios

Industry RankSector Rank
ROA -5.8%
ROE -8.73%
ROIC N/A
ROA(3y)19.54%
ROA(5y)-10.22%
ROE(3y)28.55%
ROE(5y)-14.05%
ROIC(3y)N/A
ROIC(5y)N/A
EMO Yearly ROA, ROE, ROICEMO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for EMO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMO Yearly Profit, Operating, Gross MarginsEMO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2K -2K -4K -6K

More info and screens

4

2. Health

2.1 Basic Checks

Compared to 1 year ago, EMO has less shares outstanding
EMO has less shares outstanding than it did 5 years ago.
EMO has about the same debt/assets ratio as last year.
EMO Yearly Shares OutstandingEMO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M
EMO Yearly Total Debt VS Total AssetsEMO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 1.89 indicates that EMO is not a great score, but indicates only limited risk for bankruptcy at the moment.
EMO has a debt to FCF ratio of 6.57. This is a slightly negative value and a sign of low solvency as EMO would need 6.57 years to pay back of all of its debts.
A Debt/Equity ratio of 0.50 indicates that EMO is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 6.57
Altman-Z 1.89
ROIC/WACCN/A
WACCN/A
EMO Yearly LT Debt VS Equity VS FCFEMO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

2.3 Liquidity

EMO has a Current Ratio of 4.60. This indicates that EMO is financially healthy and has no problem in meeting its short term obligations.
EMO has a Quick Ratio of 4.60. This indicates that EMO is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 4.6
Quick Ratio 4.6
EMO Yearly Current Assets VS Current LiabilitesEMO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for EMO have decreased strongly by -55.15% in the last year.
Looking at the last year, EMO shows a very strong growth in Revenue. The Revenue has grown by 51.01%.
Measured over the past years, EMO shows a very strong growth in Revenue. The Revenue has been growing by 25.08% on average per year.
EPS 1Y (TTM)-55.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2714.33%
Revenue 1Y (TTM)51.01%
Revenue growth 3Y29.33%
Revenue growth 5Y25.08%
Sales Q2Q%55.66%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EMO Yearly Revenue VS EstimatesEMO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M 4M 6M 8M 10M
EMO Yearly EPS VS EstimatesEMO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 9.64, which indicates a very decent valuation of EMO.
EMO's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.62.
Industry RankSector Rank
PE 9.64
Fwd PE N/A
EMO Price Earnings VS Forward Price EarningsEMO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 28.64
EV/EBITDA N/A
EMO Per share dataEMO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

EMO has a Yearly Dividend Yield of 6.78%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.27, EMO pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.78%

5.2 History

The dividend of EMO decreases each year by -14.49%.
EMO has paid a dividend for at least 10 years, which is a reliable track record.
EMO has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-14.49%
Div Incr Years3
Div Non Decr Years3
EMO Yearly Dividends per shareEMO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

5.3 Sustainability

EMO has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-75.8%
EPS Next 2YN/A
EPS Next 3YN/A
EMO Yearly Income VS Free CF VS DividendEMO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M

More info and screens

CLEARBRIDGE ENERGY MIDSTREAM

NYSE:EMO (2/21/2025, 8:15:43 PM)

48.96

-1.52 (-3.01%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)07-28 2025-07-28
Inst Owners28.8%
Inst Owner Change-66.56%
Ins OwnersN/A
Ins Owner Change-189.99%
Market Cap890.58M
Analysts0
Price TargetN/A
Short Float %0.11%
Short Ratio0.43
Dividend
Industry RankSector Rank
Dividend Yield 6.78%
Yearly Dividend2.36
Dividend Growth(5Y)-14.49%
DP-75.8%
Div Incr Years3
Div Non Decr Years3
Ex-Date02-21 2025-02-21 (0.33)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 9.64
Fwd PE N/A
P/S 94.34
P/FCF 28.64
P/OCF 28.64
P/B 2.18
P/tB 2.18
EV/EBITDA N/A
EPS(TTM)5.08
EY10.38%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.71
FCFY3.49%
OCF(TTM)1.71
OCFY3.49%
SpS0.52
BVpS22.42
TBVpS22.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.8%
ROE -8.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 329.45%
ROA(3y)19.54%
ROA(5y)-10.22%
ROE(3y)28.55%
ROE(5y)-14.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 6.57
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.6
Quick Ratio 4.6
Altman-Z 1.89
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-55.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2714.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)51.01%
Revenue growth 3Y29.33%
Revenue growth 5Y25.08%
Sales Q2Q%55.66%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-46.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y210.28%
FCF growth 3Y-56.95%
FCF growth 5Y-19.69%
OCF growth 1Y210.28%
OCF growth 3Y-56.95%
OCF growth 5Y-19.69%